After several months of rapid pandemic expansion, it is now apparent that the SARS-CoV-2
coronavirus interferes with smell and taste sensation in a substantial proportion of COVID-19 …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

Anecdotal clinical observation suggests that rates of chemosensory dysfunction associated
with COVID‐19 infection may be decreasing. To investigate, the National COVID Cohort …

The main neurological manifestation of COVID-19 is loss of smell or taste. The high
incidence of smell loss without significant rhinorrhea or nasal congestion suggests that …

Abstract Purpose of Review Chemosensory dysfunction in the patients with COVID-19 has
been reported frequently in the studies from different regions of the world. However, the …

Patients with recent pandemic coronavirus disease 19 (COVID-19) complain of neurological
abnormalities in sensory functions such as smell and taste in the early stages of infection …

A wealth of rapidly evolving reports suggests that olfaction and taste disturbances may be
manifestations of the novel COVID-19 pandemic. While otolaryngological societies …

Recent anecdotal and scientific reports have provided evidence of a link between COVID-19
and chemosensory impairments, such as anosmia. However, these reports have …

Chemosensory impairments have been established as a specific indicator of COVID-19.
They affect most patients and may persist long past the resolution of respiratory symptoms …

The prevalence of chemosensory dysfunction in patients with COVID-19 varies greatly
between populations. It is unclear whether such differences are due to factors at the level of …